EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor

Nils Welter iD, Jens-Peter Schenk, Jenny Wegert, Manfred Gessler, Leo Kager iD, Stefan Wagenpfeil, Marina Müller, Jean-Michel Wolff, Joerg Fuchs, Steven W Warmann, Clemens-Magnus Meier iD, Jochen Hubertus und 6 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Nils Welter und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, Saarland University Hospital, Homburg, Saar, Germany. Hauptthemen laut MEDLINE: Wilms Tumor, Kidney Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The management of clinically apparent single lesions or oligofocal nephroblastomatosis, a facultative precursor of nephroblastoma, remains debated.

Methods

We retrospectively analyzed 37 patients with clinically apparent single or oligofocal nephroblastomatosis (two to three lesions per kidney) among 2347 patients registered between 1993 and 2014 in the SIOP93‐01/GPOH and SIOP2001/GPOH renal tumor studies.

Results

Of the 37 patients, 23 had a single lesion, and 14 had oligofocal disease; 65% had a clinically apparent and/or molecularly diagnosed cancer predisposition syndrome, and 27% bilateral involvement. Preoperative chemotherapy was administered to 62%, primary surgery to 32%, and chemotherapy without surgery to 5%. Nephron‐sparing surgery was performed in 71%. In oligofocal cases, preoperative chemotherapy led to significant tumor volume reduction. Prognosis was favorable: 10‐year event‐free, nephroblastoma‐free, and overall survival rates were 77.4%, 80.7%, and 92.0%, respectively. Of 35 patients who underwent definitive surgery, 26 received short postoperative treatment (≤4 weeks) or a watch‐and‐wait approach (W&W). Three patients (11.5%) developed nephroblastoma, two of whom were successfully salvaged. Ten‐year nephroblastoma‐free survival was 74.1%, 90.0%, and 100% for short, W&W, and long postoperative treatment (>4 weeks), respectively. All 12 patients undergoing primary definitive surgery remained nephroblastoma‐free.

Conclusion

Short postoperative chemotherapy or W&W is a safe option for patients with single or oligofocal nephroblastomatosis in complete remission, provided they undergo close ultrasound monitoring. The modest relapse risk, manageable with salvage therapy, must be weighed against the toxicity of prolonged treatment, especially in infants. Both primary and delayed surgery are viable strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wilms TumorKidney NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleRetrospective StudiesMaleInfantChild, PreschoolPrognosisSurvival RateFollow-Up StudiesChildDactinomycinVincristine

Stichwörter der Autor:innen

imagingnephroblastomatosisnephrogenic restsoutcometreatment approach

Substanzen

DactinomycinVincristine

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, Saarland University Hospital, Homburg, Saar, Germany.
  • Division of Pediatric Radiology, Clinic of Interventional and Diagnostic Radiology, University Hospital, Heidelberg, Germany.
  • Department of Developmental Biochemistry, Würzburg University, Würzburg, Germany.
  • St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Institute of Medical Biometry, Epidemiology and Medical Informatics, Saarland University, Homburg, Saar, Germany.
  • Department of Pediatric Surgery and Pediatric Urology, Tübingen University Hospital, Tübingen, Germany.

ORCID-Profile: Nils Welter, Leo Kager, Clemens-Magnus Meier

Förderung

  • German

Zitieren

APA

Welter, N., Schenk, J. P., Wegert, J., Gessler, M., Kager, L., Wagenpfeil, S., Müller, M., Wolff, J. M., Fuchs, J., Warmann, S. W., Meier, C. M., Hubertus, J., Rübe, C., Vokuhl, C., Melchior, P., Tschirner, L., Graf, N., & Furtwängler, R. (2026). The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70354

Vancouver

Welter N, Schenk JP, Wegert J, Gessler M, Kager L, Wagenpfeil S, et al. The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70354

BibTeX
@article{Welter2026,
  author = {Welter, Nils and Schenk, Jens-Peter and Wegert, Jenny and Gessler, Manfred and Kager, Leo and Wagenpfeil, Stefan and Müller, Marina and Wolff, Jean-Michel and Fuchs, Joerg and Warmann, Steven W and Meier, Clemens-Magnus and Hubertus, Jochen and Rübe, Christian and Vokuhl, Christian and Melchior, Patrick and Tschirner, Lena and Graf, Norbert and Furtwängler, Rhoikos},
  title = {The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70354}
}
Kostenlos starten →